Biomarkers of post-discharge mortality among children with complicated severe acute malnutrition

Scientific Reports

Volumn 9, Issue 1, 2019, Pages

  Njunge, James M ^a,b   Gwela, Agnes ^a,b   Kibinge, Nelson K ^b   Ngari, Moses ^a,b   Nyamako, Lydia ^b   Nyatichi, Emily ^a,b   Thitiri, Johnstone ^a,b   Gonzales, Gerard Bryan ^c,h   Bandsma, Robert H J ^a,g   Walson, Judd L ^a,f   Gitau, Evelyn N ^d   Berkley, James A ^a,b,e  

^a The Childhood Acute Illness and Nutrition Network (CHAIN)   (Kenya)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c GHENT UNIVERSITY   (Belgium)

^d AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF WASHINGTON   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h Department of Molecular Biomedical Research   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLOOD; CASE CONTROL STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; MALE; MALNUTRITION; MORTALITY; TIME FACTOR;

BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; MALE; PATIENT DISCHARGE; SEVERE ACUTE MALNUTRITION; TIME FACTORS;

EID: 85064343246     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-42436-y     Document Type: Article

References (73)

1. Black, R. E. et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382(9890), 427–451 (2013).
2. Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388(10063), 3027–3035 (2016).
3. Pelletier, D. L. et al. The effects of malnutrition on child mortality in developing countries. Bull World Health Organ 73(4), 443–8 (1995).
4. Caulfield, L. E. et al. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 80(1), 193–198 (2004).
5. Nair, H. et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 381(9875), 1380–1390 (2013).
6. Man, W. D. C. et al. Nutritional status of children admitted to hospital with different diseases and its relationship to outcome in The Gambia, West Africa. Trop Med Int Health 3(8), 678–686 (1998).
7. Walson, J. L. & Berkley, J. A. The impact of malnutrition on childhood infections. Curr Opin Infect Dis 31(3), 231–236 (2018).
8. WHO. Guideline: Updates on the Management of Severe Acute Malnutrition in Infants and Children (World Health Organization, Geneva, 2013).
9. Bachou, H. et al. Reduction of unnecessary transfusion and intravenous fluids in severely malnourished children is not enough to reduce mortality. Ann Trop Paediatr 28(1), 23–33 (2008).
10. Brewster, D. R. Inpatient management of severe malnutrition: time for a change in protocol and practice. Ann Trop Paediatr 31(2), 97–107 (2011).
11. Page, A.-L. et al. Infections in children admitted with complicated severe acute malnutrition in Niger. PLoS One 8(7), e68699 (2013).
12. Maitland, K. et al. Children with severe malnutrition: can those at highest risk of death be identified with the WHO Protocol? PLOS Medicine 3(12), e500 (2006).
13. Moisi, J. C. et al. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ 89(10), 725–32, 732A (2011).
14. Ngari, M. M. et al. Mortality after inpatient treatment for severe pneumonia in children: a cohort study. Paediatr Perinat Epidemiol 31(3), 233–242 (2017).
15. Wiens, M. O. et al. Postdischarge mortality in children with acute infectious diseases: derivation of postdischarge mortality prediction models. BMJ Open 5(11) (2015).
16. Chhibber, A. V. et al. Child mortality after discharge from a health facility following suspected pneumonia, meningitis or septicaemia in rural Gambia: a cohort study. PLoS One 10(9), e0137095 (2015).
17. Veirum, J. E. et al. Increased mortality in the year following discharge from a paediatric ward in Bissau, Guinea-Bissau. Acta Pædiatrica 96(12), 1832–1838 (2007).
18. Wiens, M. O. et al. Pediatric post-discharge mortality in resource poor countries: a systematic review. PLoS One 8(6), e66698 (2013).
19. Berkley, J. A. et al. Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial. Lancet Glob Health 4(7), e464–e473 (2016).
20. Dubray, C. et al. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr 28(1), 13–22 (2008).
21. Kerac, M. et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet 374(9684), 136–44 (2009).
22. Trehan, I. et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 368(5), 425–35 (2013).
23. Nemetchek, B. et al. Paediatric postdischarge mortality in developing countries: a systematic review. BMJ Open 8(12), e023445 (2018).
24. Bourke, C. D., Berkley, J. A. & Prendergast, A. J. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol 37(6), 386–398 (2016).
25. Tate, J. R. et al. Harmonising adult and paediatric reference intervals in australia and new zealand: an evidence-based approach for establishing a first panel of chemistry analytes. Clin Biochem Rev 35(4), 213–35 (2014).
26. Karita, E. et al. CLSI-derived hematology and biochemistry reference intervals for healthy adults in Eastern and Southern Africa. PLoS One 4(2), e4401 (2009).
27. Hickmans, E. M., Finch, E. & Tonks, E. Plasma protein values in infants. Arch Dis Child 18(94), 96–97 (1943).
28. Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4, 207 (2007).
29. Bartz, S. et al. Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin Endocrinol Metab 99(6), 2128–37 (2014).
30. Rytter, M. J. H. et al. The immune system in children with malnutrition—a systematic review. PLoS One 9(8), e105017 (2014).
31. Jones, K. D. J. & Berkley, J. A. Severe acute malnutrition and infection. Paediatr Int Child Health 34(Suppl 1), 1–29 (2014).
32. Vandal, K. et al. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171(5), 2602–2609 (2003).
33. Huang, H. & Tu, L. Expression of S100 family proteins in neonatal rats with sepsis and its significance. Int J Clin Exp Pathol 8(2), 1631–9 (2015).
34. Simm, M. et al. Performance of plasma calprotectin as a biomarker of early sepsis: a pilot study. Biomark Med 10(8), 811–818 (2016).
35. Jonsson, N. et al. Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment. Crit Care Resusc 19(3), 205–213 (2017).
36. Kitabayashi, A. et al. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor- alpha production. Blood 86(6), 2220–2227 (1995).
37. Hartung, T. et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85(9), 2482–2489 (1995).
38. Opal, S. M. et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180(5), 1584–1589 (1999).
39. Zweigner, J. et al. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98(13), 3800–3808 (2001).
40. Rogers, C. L. & Rozanski, E. A. Von Willebrand Factor antigen concentration in dogs with sepsis. J Vet Intern Med 24(1), 229–230 (2010).
41. Kasten, K. R. et al. T cells are potent early mediators of the host response to sepsis. Shock 34(4), 327–336 (2010).
42. Dufour, J. H. et al. IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168(7), 3195–3204 (2002).
43. Attia, S. et al. Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study. Am J Clin Nutr 104(5), 1441–1449 (2016).
44. Reynolds, J. V. et al. Impaired gut barrier function in malnourished patients. Br J Surg 83(9), 1288–1291 (1996).
45. Amadi, B. et al. Impaired barrier function and autoantibody generation in malnutrition enteropathy in Zambia. EBioMedicine 22, 191–199 (2017).
46. Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763 (1998).
47. Klok, M. D., Jakobsdottir, S. & Drent, M. L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 8(1), 21–34 (2007).
48. Lord, G. M. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897 (1998).
49. SÁNchez-Margalet, V. et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 133(1), 11–19 (2003).
50. Santos-Alvarez, J., Goberna, R. & Sánchez-Margalet, V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194(1), 6–11 (1999).
51. Mody, A. et al. Effects of HIV infection on the metabolic and hormonal status of children with severe acute malnutrition. PLoS One 9(7), e102233 (2014).
52. Popa, C. et al. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8), 1195–8 (2005).
53. Pérez-Pérez, A. et al. Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev 35, 71–84 (2017).
54. Abella, V. et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol 13, 100 (2017).
55. Ahima, R. S., Prabakaran, D. & Flier, J. S. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest 101(5), 1020–1027 (1998).
56. Ruggeri, Z. M. The role of von Willebrand Factor in thrombus formation. Thromb Res 120(Suppl 1), S5–S9 (2007).
57. van Mourik, J. A. et al. von Willebrand Factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 94(1), 179–185 (1999).
58. Gragnano, F. et al. The role of von Willebrand Factor in vascular inflammation: from pathogenesis to targeted therapy. Mediators Inflamm 2017, 5620314 (2017).
59. Kremer Hovinga, J. A. et al. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 5(11), 2284–2290 (2007).
60. Cleland, S. J. et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci 98(5), 531–535 (2000).
61. Hingorani, A. D. et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102(9), 994–9 (2000).
62. Stenvinkel, P. Endothelial dysfunction and inflammation—is there a link? Nephrol Dial Transplant 16(10), 1968–1971 (2001).
63. Lu, H. et al. Structure and functions of angiotensinogen. Hypertens Res 39, 492 (2016).
64. Lee, J. W. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 8(2), 72–81 (2010).
65. Chistiakov, D. A. et al. Paraoxonase and atherosclerosis-related cardiovascular diseases. Biochimie 132, 19–27 (2017).
66. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 4(1), 44–57 (2008).
67. WHO. Pocket book for hospital care of children: guidelines for the management of common illness with limited resources (2005).
68. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotech 26(12), 1367–1372 (2008).
69. Cox, J. et al. Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res 10(4), 1794–1805 (2011).
70. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57(1), 289–300 (1995).
71. Team, R. C. R: A language and environment for statistical computing. R Foundation for Statistical Computing (2017).
72. Stata Corp. STATA survival analysis reference manual release 15, S. Press, Editor. Stata Press, www.stata.com p. 475 (2017).
73. Vizcaino, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotech 32(3), 223–226 (2014).